2019
DOI: 10.1093/carcin/bgz035
|View full text |Cite
|
Sign up to set email alerts
|

DIAPH2 alterations increase cellular motility and may contribute to the metastatic potential of laryngeal squamous cell carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 28 publications
0
10
0
Order By: Relevance
“…3 Despite advances in comprehensive LSCC treatment, the 5year survival rate has not decreased significantly in decades. 4 The main risk factors for a poor prognosis of LSCC are invasion and metastasis of cervical lymph nodes. 5 Furthermore, the diagnostic delay caused by the absence of obvious symptoms in the early stage is an unfavorable factor for LSCC prognosis.…”
Section: Introductionmentioning
confidence: 99%
“…3 Despite advances in comprehensive LSCC treatment, the 5year survival rate has not decreased significantly in decades. 4 The main risk factors for a poor prognosis of LSCC are invasion and metastasis of cervical lymph nodes. 5 Furthermore, the diagnostic delay caused by the absence of obvious symptoms in the early stage is an unfavorable factor for LSCC prognosis.…”
Section: Introductionmentioning
confidence: 99%
“…DIAPH2 and GASK1B (also known as FAM198B ) have been associated with cancer metastasis ( Kawamata et al 2003 ; Hsu et al 2018 ) . Particularly, DIAPH2 is involved in laryngeal squamous cell carcinoma, a type of cancer with low survival rate ( Kostrzewska-Poczekaj et al 2019 ). Finally, SELENO (also known as SEPS1 ) encodes for a protein that induces inflammatory responses as a result of cellular stress ( Curran et al 2005 ) and diabetes ( Li et al 2019 ).…”
Section: Resultsmentioning
confidence: 99%
“…Laryngeal squamous cell carcinoma (LSCC) is one of the most common head and neck squamous cell carcinomas (HNSCC) [ 1 ]. World has made great strides in LSCC treatment, nonetheless the 5-year survival rate of LSCC patients remains 68% [ 2 ].…”
Section: Introductionmentioning
confidence: 99%